Evidence map›Paper›PMID 17826414›Full record

ArticleAmerican journal of obstetrics and gynecology2007

Understanding the mechanism of learning enhancement: NMDA and GABA receptor expression.

Laura Toso, Andrea Johnson, Stephanie Bissell, Robin Roberson, Daniel Abebe, Catherine Y Spong

Open access · greenAbstract read
In one paragraph

Article in American journal of obstetrics and gynecology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Laura TosoUnit on Perinatal and Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA. tosol@mail.nih.gov
Andrea Johnson
Stephanie Bissell
Robin Roberson
Daniel Abebe
Catherine Y Spong
National Institute on Alcohol Abuse and Alcoholism · USEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

Intramural NIH HHS Z99 HD999999
6 · The paper itself

Abstract

objectiveThe administration of neurotrophic peptides NAPVSIPQ (NAP) + SALLRSIPA (SAL) to aged mice resulted in significant learning enhancement. N-methyl-D-aspartate (NMDA) and gamma-aminobutyric acid (GABA) receptors are fundamental for learning because they are the major modulators of the long-term potentiation, the electrophysiologic mechanism for learning. Also, these receptors have been shown to be involved in NAP + SAL prevention of learning deficit in a mouse model for fetal alcohol syndrome, when administered prenatally during development. Our objective was to test whether NMDA and GABA receptors contribute to the learning enhancement that is induced by the peptides after adult administration. STUDY

designAged (14.5 months) male mice were treated for 10 consecutive days with placebo or D-NAP + D-SAL (20 microg, by gavage). At the end of the treatment, brains were harvested. Calibrator-normalized relative real-time polymerase chain reaction was performed with primers for GABA-(A)beta3, GABA-(A)alpha5, and the NMDA receptor subunits NR2A and NR2B, with GAPDH standardization. Statistical analysis included analysis of variance, with a probability value that was considered significant at <.05.

resultsFive control brains and 6 brains from animals that were treated with NAP + SAL were collected. There was no difference in GABA-(A)beta3, GABA-(A)alpha5, NR2A, and NR2B subunits after adult administration of NAP + SAL, as compared with the controls (P > .05).

conclusionPostnatal treatment with NAP + SAL induced learning enhancement in aged mice with a mechanism that does not involve alteration in NMDA and GABA receptor expression. Thus, the mechanism of learning enhancement might be different for a developing fetus than an adult or in the absence of a perturbing agent.

Indexed as

Age FactorsAnimalsBrainLearningLong-Term PotentiationMaleMiceMice, Inbred C57BLModels, AnimalNeuroprotective AgentsOligopeptidesReceptors, GABAReceptors, N-Methyl-D-AspartatedavunetideNeuroprotective AgentsOligopeptidesReceptors, GABAReceptors, N-Methyl-D-Aspartateseryl-alanyl-leucy-leucyl-arginyl-seryl-isoleucyl-prolyl-alanine

Identifiers

PMID17826414
PMCPMC2001299
OpenAlexW2022409900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.